Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer - Peeters, M; Price, TJ; Cervantes, A (J Clin Oncol, 2010)